Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 18:23:e936250.
doi: 10.12659/AJCR.936250.

Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation

Affiliations
Case Reports

Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation

Marcel Cerqueira Cesar Machado et al. Am J Case Rep. .

Abstract

BACKGROUND The incidence of abnormal liver function, mainly aspartate aminotransferase and alanine aminotransferase elevations, in patients with COVID-19 is not uncommon, but persistent liver damage after the acute phase of the disease is uncommon and has been recently recognized as a new entity named post-COVID-19 cholangiopathy. CASE REPORT We report a clinical case with progressive cholestatic disease following severe COVID-19. AST and ALT peaked at hospital admission and while its serum concentration went down, bilirubin and cholestatic liver enzymes started to increase, reaching the maximum at day 122. Magnetic resonance imaging (MRI) revealed a diffuse irregularity of intra- and extrahepatic bile ducts, with multiple focal strictures alternating with mild focal dilations of the biliary tree, suggesting a sclerosing cholangiopathy. A transjugular liver biopsy showed a prominent bile ductular reaction, cholangiocyte injury, inflammatory infiltrate rich in neutrophils, biliary infarctions, marked cholestasis, and portal fibrosis, suggesting the diagnosis of post-Covid-19 secondary sclerosing cholangitis. The patient evolved with a continuous deterioration of liver functions, but liver transplantation was not performed due to his poor clinical condition. CONCLUSIONS Post-COVID-19 SSC is a severe disease with no effective clinical treatment and has liver transplantation as the only treatment for a few selected patients.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1.
Figure 1.
Magnetic resonance cholangiopancreatography image showing multiple strictures alternating with focal dilations of intra- and extrahepatic bile ducts (white arrow).
Figure 2.
Figure 2.
A bile infarct associated with ductular reaction and degenerative cholangiocyte injury (10×, white arrow).
Figure 3.
Figure 3.
Bile ductular proliferation accompanied by neutrophils. Cholangiocyte cytoplasmic vacuolization injury (arrow, 40×).
Figure 4.
Figure 4.
Portal fibrosis and bile ductular reaction – proliferation of small ductules at the periphery of the portal tract accompanied by neutrophils (10×, white arrow).

References

    1. Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73:566–74. - PMC - PubMed
    1. Brandão Neto RA, Marchini JF, Marino LO, et al. Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study. PLoS One. 2021;16:e0244532. - PMC - PubMed
    1. Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: A novel entity. Am J Gastroenterol. 2021;116:1077–82. - PubMed
    1. Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD Expert Panel Consensus Statement. Hepatol Baltim Md. 2020;72:287–304. - PMC - PubMed
    1. Hundt MA, Deng Y, Ciarleglio MM, et al. Abnormal liver tests in COVID-19: A retrospective observational cohort study of 1,827 patients in a Major U.S. Hospital Network. Hepatology. 2020;72:1169–76. - PMC - PubMed

Publication types

MeSH terms